Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;28(8):e70016.
doi: 10.1002/jia2.70016.

High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East Africa

Affiliations

High peak viraemia followed by spontaneous HIV-1 control in women living with HIV-1 subtype A1 in East Africa

Yifan Li et al. J Int AIDS Soc. 2025 Aug.

Abstract

Introduction: Cases of spontaneous control of HIV-1 can help define strategies to induce remission. Since the identification of viral control in the absence of treatment typically occurs after a prolonged period post-HIV-1 diagnosis, our knowledge of the early events after HIV-1 acquisition that led to viral control is limited.

Methods: The RV217 prospective cohort enrolled 2276 participants in East Africa (Kenya, Uganda, Tanzania) and Thailand between 2009 and 2015. We analysed HIV-1 sequences and clinical data from 102 individuals who were diagnosed with acute HIV-1 infection and had a negative HIV-1 RNA test in the week before. We focused on 69 participants with longitudinal follow-up and identified viraemic controllers who maintained viral loads <2000 copies/ml for over a year without treatment. We evaluated viral genetic and clinical features that are associated with viral control.

Results: Eleven women from East Africa showed control of viral replication for an average duration of 891 (range: 405-1425) days within an average of 130 days from diagnosis. The majority were living with subtype A1 (n = 6), or A1 recombinant strains (n = 4), with one living with subtype D; 10 were from Kenya, one from Uganda. Controllers had significantly slower CD4+ T cell decline (p = 0.028) and higher Natural Killer (NK) cell counts (p = 0.047) than non-controllers, but none carried human leukocyte antigen (HLA) alleles previously reported to be associated with viral control. Peak viraemia was recorded at an average of 541 million copies/ml with no difference between controllers and non-controllers (p = 0.97). Viral loads became lower in controllers (3459 copies/ml) than in non-controllers (23,157 copies/ml) as early as nadir viraemia (p = 0.009), with a more significant difference observed at set point (1069 vs. 24,084 copies/ml, respectively; p<0.0001).

Conclusions: Our findings confirm the role of HIV-1 subtype A1 in mediating viral control. The fact that controllers showed high viral loads in acute infection indicates that these viruses were not intrinsically impaired for replication, underlining the intersection between host immunity and favourable genotypes in the subsequent control of HIV-1. These data suggest that conducting HIV-1 remission studies in East Africa could provide favourable conditions to achieve durable post-treatment control of viraemia.

Keywords: HIV‐1; HIV‐1 subtype A1; acute infection; peak viraemia; persons living with HIV‐1; viraemic controllers.

PubMed Disclaimer

Conflict of interest statement

The investigators have adhered to the policies for protection of human participants as prescribed in AR 70–25. Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication.

Figures

Figure 1
Figure 1
Rapid control of viral loads in 11 participants. (A) Viral trajectories during the first year after HIV‐1 diagnosis for 102 RV217 participants who were ART‐naive. Blue lines indicate viraemic controllers. (B) Viral trajectory of the 11 viraemic controllers (the participant ID is shown above each VL plot). Red dashed lines indicate ART initiation; black horizontal lines indicate VL = 2000 copies/ml.
Figure 2
Figure 2
HIV‐1 subtype A1 associated with viraemic control. (A) Distribution of subtypes using env sequences in viraemic controllers (in blue) and non‐controllers (in orange). (B) Phylogeny reconstructed from consensus sequences for RV217 participants with branches colour‐coded to show the reconstructed ancestral estimates of SPVL; subtypes are denoted on the right of the figure (“A1rec” corresponds to the different recombinants including subtype A1 with either subtypes C and D or both).
Figure 3
Figure 3
Similar viral loads in viraemic controllers and non‐controllers in acute HIV‐1 infection. (A) Comparison of peak VL, nadir VL and set point VL in viraemic controllers (blue) and non‐controllers (orange) during the first year after diagnosis. (B) Average NK cell counts and (C) CD4+ T cell slope during the first year after diagnosis in viraemic controllers and non‐controllers with single founders in East Africa. (D) Env median pairwise diversity and (E) divergence from the consensus based on nucleotide sequences sampled within 42 days of infection in viraemic controllers and non‐controllers with single founders in East Africa. p values of Wilcoxon rank sum tests are shown.

References

    1. Okulicz JF, Lambotte O. Epidemiology and clinical characteristics of elite controllers. Curr Opin HIV AIDS. 2011;6(3):163–8. - PubMed
    1. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, Saah AJ, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV‐1 infection. Nat Med. 1996;2(4):405–11. - PubMed
    1. International HIVCS, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, et al. The major genetic determinants of HIV‐1 control affect HLA class I peptide presentation. Science. 2010;330(6010):1551–7. - PMC - PubMed
    1. Walker BD. Elite control of HIV infection: implications for vaccines and treatment. Top HIV Med. 2007;15(4):134–6. - PubMed
    1. Berg MG, Olivo A, Harris BJ, Rodgers MA, James L, Mampunza S, et al. A high prevalence of potential HIV elite controllers identified over 30 years in Democratic Republic of Congo. EBioMedicine. 2021;65:103258. - PMC - PubMed